Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech .

Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent Office determines whether two of the three Moderna patents at ...

The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax.

SK bioscience won a patent case against Moderna in Korea, impacting mRNA technology development and potential vaccine exports to developing countries.

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a continuing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.

Rather, Moderna is referring to an outbreak sparked by a different coronavirus, Middle East Respiratory Syndrome (MERS). That research began in 2014—five years before Covid-19’s emergence.

Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech. The ...

Moderna said on Friday (May 17) the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech. The ...

Moderna wins patent case in Europe against Pfizer, BioNTech over COVID shot Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...

Moderna has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty after suing them in 2022 for allegedly copying its mRNA technology ...